National cholesterol education program recommendations for cholesterol testing in young adults: A science-based approach

Circulation

Volumn 95, Issue 6, 1997, Pages 1646-1650

  Cleeman, James I ^a   Grundy, Scott M ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

adults, young; cholesterol; cholesterol screening; coronary disease; lipoproteins

Indexed keywords

ACUTE HEART INFARCTION; AGING; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DIET; FAMILY HISTORY; HEALTH PROMOTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING; UNSTABLE ANGINA PECTORIS;

EID: 0030948586     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.6.1646     Document Type: Review

References (27)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Cholesterol Education Program: second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1329-1445.
3. American College of Physicians. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 1996;124:515-517.
4. Garber AM, Browner WS. Cholesterol screening guidelines: consensus, evidence, and common sense. Circulation. 1997;95: 1642-1645.
5. Expert Panel on Population Strategies for Blood Cholesterol Reduction. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: a statement from the National Cholesterol Education Program. Circulation. 1991;83:2154-2232.
6. Murray DM, Luepker RV, Pirie PL, Grimm RH Jr, Bloom E, Davis MA, Blackburn H. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Prev Med. 1986;15:661-672.
7. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP, for the PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17:95-107.
8. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang K-Y, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328:313-318.
9. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA. 1987;257: 2176-2180.
10. Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. Br Med J. 1994;308:363-366.
11. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J. 1994;308:367-373.
12. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;334: 1383-1389.
13. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
14. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333:1301-1307.
15. Kuller LH. Magnitude of the problem. In: Proceedings of the National Heart, Lung, and Blood Institute Symposium on Rapid Identification and Treatment of Acute Myocardial Infarction: September 1991. Bethesda, Md: National Heart, Lung, and Blood Institute; 1992, NIH publication No. 91-3035.
16. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol. 1985;5:141B-149B.
17. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993; 887:1781-1791.
18. Sempos CT, Cleeman JI, Carrol MK, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, Rifkind BM. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993;269:3009-3014.
19. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Br Med J. 1991;303:893-896.
20. Karhapaa P, Malkki M, Laakso M. Isolated low HDL cholesterol: an insulin-resistance state. Diabetes. 1994;43:411-417.
21. Denke MA. Cholesterol-lowering diets: a review of the evidence. Arch Intern Med. 1995;155:17-26.
22. Federation of American Societies for Experimental Biology, Life Sciences Research Office. Third Report on Nutrition Monitoring in the United States: Vol 1. Washington, DC: US Government Printing Office; 1995.
23. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RB, Gordon DJ, Burt VL, Brown CD, Lippel K, Cleeman JI. Declining serum cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993; 269:3002-3008.
24. National Heart, Lung, and Blood Institute Cholesterol Awareness Surveys, 1995. National Heart, Lung, and Blood Institute, Bethesda, MD: Press Conference; December 4, 1995. Press conference information.
25. Elton PJ, Ryman A, Hammer M, Page F. Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration. J Epidemiol Commun Health. 1994;48:22-25.
26. Denke MA, Sempos CT, Grundy SM. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med. 1993;153:1093-1103.
27. Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154:401-410.